Issue 40, 2023

Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance

Abstract

Polyprodrugs have been recognized as promising carrier-free drug delivery systems (DDSs) for tumor chemotherapy in recent years, showing distinct superiority in comparison with the conventional polymer prodrugs. In the present work, the structure–property relationship of polyprodrugs was explored from the perspective of molecular structure, by discussing the effects of the conjugations and linkers on their drug content and drug releasing performance, including drug releasing rate and drug releasing selectivity, as well as the anti-tumor performance of the released drugs. Moreover, the future challenges in the design of polyprodrug-based DDSs with high anti-tumor efficacy were also highlighted.

Graphical abstract: Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance

Article information

Article type
Highlight
Submitted
28 Jūl. 2023
Accepted
19 Sept. 2023
First published
20 Sept. 2023

J. Mater. Chem. B, 2023,11, 9565-9571

Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance

P. Liu, J. Mater. Chem. B, 2023, 11, 9565 DOI: 10.1039/D3TB01700A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements